Information Provided By:
Fly News Breaks for February 2, 2018
DPLO
Feb 2, 2018 | 06:26 EDT
Deutsche Bank analyst Glen Santangelo downgraded Diplomat Pharmacy to Hold while raising his price target for the shares to $29 from $22. The analyst believes a Hold rating is more appropriate following the recent rally in the shares. He believes the stock is starting to discount further acquisitions and the potential for a takeout.
News For DPLO From the Last 2 Days
There are no results for your query DPLO